Crude Oil Throughput Rises 2.9% In September On Firm Demand
Refiners' crude oil throughput in September edged higher from the previous month, government data showed on Friday, as refineries boosted output to meet surging demand.
Refiners processed 4.45 million barrels per day (bpd) (18.21 million tonnes) of crude oil last month, up from the 4.36 million bpd in August, which was the lowest in 10 months.
"Refiners have been boosting throughput in order to meet demand during the festive season. Demand is expected to increase compared to previous months, as people travel more during festivities," Refinitiv analyst Ehsan Ul Haq said.
On a year-on-year basis, refiners' crude oil throughput in September rose about 2.9 per cent, while crude oil production fell about 1.7 per cent to around 600,000 bpd (2.44 million tonnes), the data showed.
Indian refiners operated at an average rate of 88.69 per cent of capacity in September, up from 86.89 per cent in August, the government data showed.
Reliance Industries Ltd, the operator of the world's biggest refining complex, imported nearly 12 per cent more oil in September than in August at 1.2 million bpd.
"Coal shortages are also resulting in some fuel switching to oil-related products, which is encouraging refiners to boost runs. However, continued high oil prices have the potential to lead to some demand destruction," Ul Haq said.
The country's September fuel consumption crawled higher as economic activity continued to ramp up, but soaring global oil prices pose a threat to recovery in the world's third-biggest oil importer and consumer.
Last month, India signalled a spike in oil prices could speed up the transition to alternative energy sources.Â
Meanwhile, natural gas output jumped 26.6 per cent to 2.90 billion cubic metres, the data showed.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.